Our R&D Analytical Laboratory is equipped with state-of-the-art instruments that drive innovation in pharmaceutical research. With sophisticated technologies like High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Gas Chromatography Mass Spectrometry (GCMS), Inductively Coupled Plasma Mass Spectrometry (ICP-MS), and Liquid Chromatography Mass Spectrometry (LCMS), we push the boundaries of drug development. These advanced tools enable us to tackle the complexities of various dosage forms, including complex molecules and Novel Drug Delivery Systems (NDDS), ensuring precise quality evaluation.
Research & Development
Analytical
Cutting-Edge Analytical Capabilities for Advanced Research
Ensuring Consistency across Diverse Formulations
The R&D Analytical Laboratory plays a crucial role in ensuring the quality and consistency of Active Pharmaceutical Ingredients (APIs) and finished pharmaceutical formulations, such as injectables, complex injectables, topical products, nasal sprays, and solid oral dosage forms. Our rigorous testing processes ensure that every product meets the highest standards of safety, efficacy, and reliability.
Advanced Analytical Solutions at Every Stage
Our laboratory is at the forefront of analytical science, offering a wide range of specialized services including analytical method development and validation, stability studies, and physicochemical characterization of drug substances and products. We conduct In-vitro bioavailability/bioequivalence (BA/BE) studies, Elemental Impurities studies, Extractable and Leachable studies, Nitrosamine Risk Assessments, and In-Vitro Release Tests (IVRT) and In-Vitro Permeation Tests (IVPT) for topical dosage forms. These activities are designed to ensure that our products not only comply with regulatory standards but exceed expectations in performance and safety.
